TG Therapeutics Reaches Analyst Target Price
25/4 13:00
In recent trading, shares of TG Therapeutics Inc (Symbol: TGTX) have crossed above the average analyst 12-month target price of $40.00, changing hands for $40.30/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on...